ANZ Nicotinamide Adenine Dinucleotide (nad) Products Market Size & Outlook

The nicotinamide adenine dinucleotide (nad) products market in ANZ is expected to reach a projected revenue of US$ 239.0 million by 2033. A compound annual growth rate of 14.3% is expected of ANZ nicotinamide adenine dinucleotide (nad) products market from 2025 to 2033.
Revenue, 2024 (US$M)
$73.2
Forecast, 2033 (US$M)
$239.0
CAGR, 2025 - 2033
14.3%
Report Coverage
ANZ

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

ANZ nicotinamide adenine dinucleotide (nad) products market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

ANZ nicotinamide adenine dinucleotide (nad) products market highlights

  • The ANZ nicotinamide adenine dinucleotide (nad) products market generated a revenue of USD 73.2 million in 2024 and is expected to reach USD 239.0 million by 2033.
  • The ANZ market is expected to grow at a CAGR of 14.3% from 2025 to 2033.
  • In terms of segment, oral supplements was the largest revenue generating product in 2024.
  • Topical Products is the most lucrative product segment registering the fastest growth during the forecast period.


Nicotinamide adenine dinucleotide (nad) products market data book summary

Market revenue in 2024USD 73.2 million
Market revenue in 2033USD 239.0 million
Growth rate14.3% (CAGR from 2025 to 2033)
Largest segmentOral supplements
Fastest growing segmentTopical Products
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationOral Supplements, Topical Products, Others(NAD Injections, NAD IV, Nad Nasal Spray)


Other key industry trends

  • In terms of revenue, ANZ accounted for 2.1% of the global nicotinamide adenine dinucleotide (nad) products market in 2024.
  • Country-wise, China is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China nicotinamide adenine dinucleotide (nad) products market is projected to lead the regional market in terms of revenue in 2033.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 295.0 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nicotinamide Adenine Dinucleotide (NAD) Products Market Companies

Name Profile # Employees HQ Website
HPN+ View profile 101-250 Gronau, Nordrhein-Westfalen, Germany, Europe https://hpnplus.de/
Wonderfeel Biosciences View profile 11-50 San Francisco, California, United States, North America https://www.getwonderfeel.com
Cata-Kor View profile 1-10 Wilmington, Delaware, United States, North America https://www.catakor.com
Elysium View profile 11-50 New York, New York, United States, North America http://www.elysiumhealth.com
Niagen Bioscience View profile 101-250 Los Angeles, California, United States, North America https://www.niagenbioscience.com/
Codeage LLC View profile - - -
Thorne Research Inc. View profile 251-500 New York, New York, United States, North America https://www.thorne.com
Nutricost View profile 101-250 Orem, Utah, United States, North America https://nutricost.com
Renue By Science View profile - Jacksonville, Florida, United States, North America https://renuebyscience.com/
Life Extension View profile 251-500 Fort Lauderdale, Florida, United States, North America https://www.lifeextension.com/

ANZ nicotinamide adenine dinucleotide (nad) products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nicotinamide adenine dinucleotide (nad) products market will help companies and investors design strategic landscapes.


Oral supplements was the largest segment with a revenue share of 83.06% in 2024. Horizon Databook has segmented the ANZ nicotinamide adenine dinucleotide (nad) products market based on oral supplements, topical products, others(nad injections, nad iv, nad nasal spray) covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to ANZ nicotinamide adenine dinucleotide (nad) products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of ANZ nicotinamide adenine dinucleotide (nad) products market databook

  • Our clientele includes a mix of nicotinamide adenine dinucleotide (nad) products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the ANZ nicotinamide adenine dinucleotide (nad) products market , including forecasts for subscribers. This country databook contains high-level insights into ANZ nicotinamide adenine dinucleotide (nad) products market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

ANZ Product - Nicotinamide Adenine Dinucleotide (nad) Products Market size, 2024 - 2033 (US$M)

ANZ Nicotinamide Adenine Dinucleotide (NAD) Products Market Outlook Share, 2024 & 2033 (US$M)

ANZ Product - Nicotinamide Adenine Dinucleotide (nad) Products Market size, 2024 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online